# Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality

Study · id `cardio:ct-nct03112980` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03112980](<https://clinicaltrials.gov/study/NCT03112980>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03112980

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1414 participants.

## Technical summary

Registry record NCT03112980. Randomized; no masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1414 participants (enrolled count; ClinicalTrials.gov record NCT03112980, source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)
- Started: 2017-05-10 (actual) (ClinicalTrials.gov record NCT03112980, source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT03112980, source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)
- Completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT03112980, source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT03112980, source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03112980-2026-05-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
- Acronym: DEDICATE
- Condition: Aortic Valve Stenosis
- Intervention (Device): Transcatheter aortic valve implantation
- Intervention (Procedure): Surgical aortic valve replacement
- Lead sponsor: Universitätsklinikum Hamburg-Eppendorf
- Lead sponsor class: OTHER
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER
- Collaborator: The German Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Universitätsklinikum Hamburg-Eppendorf (`cardio:org-universitatsklinikum-hamburg-eppendorf`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)

## Provenance

Content hash: 9643427c2bca3f4bffd3989d39155d1ff63f0028cb62e13f30942d46fd9ba7a5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
